Search research articles
Contact Us
Filters
Showing results (11-20 of 28) with videos related to
Page
of 3
Sort By:
Bioorganic & Medicinal Chemistry Letters
|
November 27, 1999
Synthesis and evaluation of benzoxazinones as HIV-1 reverse transcriptase inhibitors. Analogs of Efavirenz (SUSTIVA)
M Patel, R J McHugh, B C Cordova, et al.
Nucleic Acids Research
|
October 11, 1994
Genetic Bit Analysis: a solid phase method for typing single nucleotide polymorphisms
T T Nikiforov, R B Rendle, P Goelet, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 7, 1999
Purin-8-ones as corticotropin-releasing hormone (CRH-R1) receptor antagonists
J P Beck, A G Arvanitis, M A Curry, et al.
Nucleic Acids Research
|
May 15, 1996
Potent antisense oligonucleotides to the human multidrug resistance-1 mRNA are rationally selected by mapping RNA-accessible sites with oligonucleotide libraries
S P Ho, D H Britton, B A Stone, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 17, 2001
Synthesis and evaluation of efavirenz (Sustiva) analogues as HIV-1 reverse transcriptase inhibitors: replacement of the cyclopropylacetylene side chain
A J Cocuzza, D R Chidester, B C Cordova, et al.
Science (New York, N.Y.)
|
October 16, 1987
A system for rapid DNA sequencing with fluorescent chain-terminating dideoxynucleotides
J M Prober, G L Trainor, R J Dam, et al.
Chemistry & Biology
|
January 5, 2002
Drug design with a new transition state analog of the hydrated carbonyl: silicon-based inhibitors of the HIV protease
C A Chen, S M Sieburth, A Glekas, et al.
Bioorganic & Medicinal Chemistry Letters
|
October 16, 1999
Synthesis and evaluation of analogs of Efavirenz (SUSTIVA) as HIV-1 reverse transcriptase inhibitors
M Patel, S S Ko, R J McHugh, et al.
Biochemical Pharmacology
|
June 17, 2000
Selective inhibition of bacterial dihydroorotate dehydrogenases by thiadiazolidinediones
J Marcinkeviciene, M J Rogers, L Kopcho, et al.
Journal of Medicinal Chemistry
|
June 19, 1998
Nonsymmetric P2/P2' cyclic urea HIV protease inhibitors. Structure-activity relationship, bioavailability, and resistance profile of monoindazole-substituted P2 analogues
G V De Lucca, U T Kim, J Liang, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 28) with videos related to
Sort By:
Page
of 3
Bioorganic & Medicinal Chemistry Letters
|
November 27, 1999
Synthesis and evaluation of benzoxazinones as HIV-1 reverse transcriptase inhibitors. Analogs of Efavirenz (SUSTIVA)
M Patel, R J McHugh, B C Cordova, et al.
Nucleic Acids Research
|
October 11, 1994
Genetic Bit Analysis: a solid phase method for typing single nucleotide polymorphisms
T T Nikiforov, R B Rendle, P Goelet, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 7, 1999
Purin-8-ones as corticotropin-releasing hormone (CRH-R1) receptor antagonists
J P Beck, A G Arvanitis, M A Curry, et al.
Nucleic Acids Research
|
May 15, 1996
Potent antisense oligonucleotides to the human multidrug resistance-1 mRNA are rationally selected by mapping RNA-accessible sites with oligonucleotide libraries
S P Ho, D H Britton, B A Stone, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 17, 2001
Synthesis and evaluation of efavirenz (Sustiva) analogues as HIV-1 reverse transcriptase inhibitors: replacement of the cyclopropylacetylene side chain
A J Cocuzza, D R Chidester, B C Cordova, et al.
Science (New York, N.Y.)
|
October 16, 1987
A system for rapid DNA sequencing with fluorescent chain-terminating dideoxynucleotides
J M Prober, G L Trainor, R J Dam, et al.
Chemistry & Biology
|
January 5, 2002
Drug design with a new transition state analog of the hydrated carbonyl: silicon-based inhibitors of the HIV protease
C A Chen, S M Sieburth, A Glekas, et al.
Bioorganic & Medicinal Chemistry Letters
|
October 16, 1999
Synthesis and evaluation of analogs of Efavirenz (SUSTIVA) as HIV-1 reverse transcriptase inhibitors
M Patel, S S Ko, R J McHugh, et al.
Biochemical Pharmacology
|
June 17, 2000
Selective inhibition of bacterial dihydroorotate dehydrogenases by thiadiazolidinediones
J Marcinkeviciene, M J Rogers, L Kopcho, et al.
Journal of Medicinal Chemistry
|
June 19, 1998
Nonsymmetric P2/P2' cyclic urea HIV protease inhibitors. Structure-activity relationship, bioavailability, and resistance profile of monoindazole-substituted P2 analogues
G V De Lucca, U T Kim, J Liang, et al.
Page
of 3